| Title |
Breast MRI: EUSOBI recommendations for women’s information
|
|---|---|
| Published in |
European Radiology, May 2015
|
| DOI | 10.1007/s00330-015-3807-z |
| Pubmed ID | |
| Authors |
Ritse M. Mann, Corinne Balleyguier, Pascal A. Baltzer, Ulrich Bick, Catherine Colin, Eleanor Cornford, Andrew Evans, Eva Fallenberg, Gabor Forrai, Michael H. Fuchsjäger, Fiona J. Gilbert, Thomas H. Helbich, Sylvia H. Heywang-Köbrunner, Julia Camps-Herrero, Christiane K. Kuhl, Laura Martincich, Federica Pediconi, Pietro Panizza, Luis J. Pina, Ruud M. Pijnappel, Katja Pinker-Domenig, Per Skaane, Francesco Sardanelli, for the European Society of Breast Imaging (EUSOBI), with language review by Europa Donna–The European Breast Cancer Coalition |
| Abstract |
This paper summarizes information about breast MRI to be provided to women and referring physicians. After listing contraindications, procedure details are described, stressing the need for correct scheduling and not moving during the examination. The structured report including BI-RADS® categories and further actions after a breast MRI examination are discussed. Breast MRI is a very sensitive modality, significantly improving screening in high-risk women. It also has a role in clinical diagnosis, problem solving, and staging, impacting on patient management. However, it is not a perfect test, and occasionally breast cancers can be missed. Therefore, clinical and other imaging findings (from mammography/ultrasound) should also be considered. Conversely, MRI may detect lesions not visible on other imaging modalities turning out to be benign (false positives). These risks should be discussed with women before a breast MRI is requested/performed. Because breast MRI drawbacks depend upon the indication for the examination, basic information for the most important breast MRI indications is presented. Seventeen notes and five frequently asked questions formulated for use as direct communication to women are provided. The text was reviewed by Europa Donna-The European Breast Cancer Coalition to ensure that it can be easily understood by women undergoing MRI. • Information on breast MRI concerns advantages/disadvantages and preparation to the examination • Claustrophobia, implantable devices, allergic predisposition, and renal function should be checked • Before menopause, scheduling on day 7-14 of the cycle is preferred • During the examination, it is highly important that the patient keeps still • Availability of prior examinations improves accuracy of breast MRI interpretation. |
Mendeley readers
The data shown below were compiled from readership statistics for 332 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | <1% |
| Japan | 1 | <1% |
| Portugal | 1 | <1% |
| Germany | 1 | <1% |
| Unknown | 327 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 43 | 13% |
| Researcher | 33 | 10% |
| Other | 31 | 9% |
| Student > Ph. D. Student | 31 | 9% |
| Student > Postgraduate | 28 | 8% |
| Other | 80 | 24% |
| Unknown | 86 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 132 | 40% |
| Nursing and Health Professions | 21 | 6% |
| Unspecified | 16 | 5% |
| Engineering | 13 | 4% |
| Biochemistry, Genetics and Molecular Biology | 8 | 2% |
| Other | 39 | 12% |
| Unknown | 103 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 June 2015.
All research outputs
#20,302,535
of 22,840,638 outputs
Outputs from European Radiology
#3,300
of 4,122 outputs
Outputs of similar age
#224,057
of 267,761 outputs
Outputs of similar age from European Radiology
#56
of 73 outputs
Altmetric has tracked 22,840,638 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,122 research outputs from this source. They receive a mean Attention Score of 4.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 267,761 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.